On June 25th, 2018, Glaukos Corporation announced it received premarket approval (PMA) from the FDA for the iStent inject® Trabecular Micro-Bypass System.  The iStent inject® is indicated for the reduction of intraocular pressure (IOP) in adult mild-to-moderate primary open-angle glaucoma (POAG) patients who are also undergoing cataract surgery. In order to achieve their goal of transforming the… Read More